Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

449842

registered interest
date	02/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	IVF: Donors
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what guidance his Department issues to sperm banks on the grounds for rejecting donors.
tabling member constituency	East Worthing and Shoreham
tabling member printed	Tim Loughton
uin	25536
answer	answer is ministerial correction date of answer 05/02/2016 answer text <p>The Human Fertilisation and Embryology Authority (HFEA) issues guidance to licensed clinics, including sperm banks, on donor recruitment, assessment and screening in the HFEA Code of Practice. A copy of which is attached.</p><p>The HFEA requires clinics to select donors on the basis of their age, health and medical history, provided on a questionnaire and through a personal interview performed by a qualified and trained healthcare professional. This assessment must include relevant factors that may assist in identifying and screening out persons whose donations could present a health risk to others, such as the possibility of transmitting diseases, (such as sexually transmitted infections) or health risks to themselves (e.g. the risks associated with the egg collection procedure or the psychological consequences of being a donor).</p><p>Clinics should ensure that its procedures for recruiting donors are fair and non-discriminatory. The HFEA has never required or endorsed prohibiting people with dyslexia, dyspraxia, attention deficit disorder, attention deficit hyperactivity disorder and other disorders from becoming sperm donors. In relation to the recent press coverage about a particular centre, the HFEA has clarified its requirements for selecting donors with this centre, and has reviewed all the exemptions cited in the centre’s materials, to ensure that all future donors are treated fairly and in accordance with the law.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 05/02/2016 13:12:09 answering member 3918 label Biography information for Jane Ellison attachment 1 file name pq25536 doc.pdf title HFEA Code of Practice
tabling member	114 label Biography information for Tim Loughton

449847

registered interest
date	02/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Sugar: Taxation
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what meetings (a) he, (b) the Minister for Public Health and (c) his special advisers had with representatives of the People Against Sugar Tax campaign in the last six months.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	25472
answer	answer is ministerial correction date of answer 05/02/2016 answer text <p>Details of all Ministerial meetings with external stakeholders are published quarterly in arrears on the GOV.UK website. The latest publication which covers meetings between July and September 2015 is available at:</p><p> </p><p><a href="https://www.gov.uk/government/publications/ministerial-gifts-hospitality-travel-and-external-meetings-2015" target="_blank">https://www.gov.uk/government/publications/ministerial-gifts-hospitality-travel-and-external-meetings-2015</a></p><p><strong> </strong></p><p>Information for October to December 2015 will be published at the end of March.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 05/02/2016 13:05:58 answering member 3918 label Biography information for Jane Ellison
tabling member	1506 label Biography information for Andrew Gwynne

449973

registered interest
date	02/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Zika Virus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what protocol is in place in the event of a person in the UK testing positive for the Zika virus.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	25417
answer	answer is ministerial correction date of answer 05/02/2016 answer text <p>In the United Kingdom, testing for Zika virus is carried out in the Public Health EnglandRare and Imported Pathogens Laboratory at Porton Down. In the event of a positive result, the clinicians caring for the patient are informed immediately, as well as local Public Health officials. The clinicians will be referred to the national guidance for further advice on management and follow-up. The majority of people (roughly 80%) infected do not have symptoms. For those with symptoms, <a href="http://ecdc.europa.eu/en/publications/_layouts/forms/Publication_DispForm.aspx?List=4f55ad51-4aed-4d32-b960-af70113dbb90&amp;ID=1413" target="_blank">Zika virus generally causes a mild, short-lived (2 to 7 days) illness</a>.</p><p> </p><p>In the case of a pregnant woman, the guidance suggests referral to a fetal medicine service for further assessment, including an ultrasound scan. Samples will also be tested for other infections prevalent in the geographical region that the patient has visited, and which may present with similar symptoms, such as dengue.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 05/02/2016 12:59:13 answering member 3918 label Biography information for Jane Ellison
tabling member	1506 label Biography information for Andrew Gwynne

449393

registered interest
date	01/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Food
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions (a) Ministers, (b) Special Advisers and (c) senior officials in his Department have had with representatives of (i) the Food and Drink Federation, (ii) Coca-Cola, (iii) PepsiCo and (iv) the British Soft Drinks Association in each of the last 18 months; and what the subject was of each such meeting.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	24988
answer	answer is ministerial correction date of answer 04/02/2016 answer text <p>Details of all Ministerial and Special Adviser meetings with external stakeholders are published quarterly in arrears on the GOV.UK website.</p><p> </p><p>Information for 2014 is available at:</p><p> </p><p><a href="http://www.gov.uk/government/publications/ministerial-gifts-hospitality-travel-and-external-meetings-2014" target="_blank">www.gov.uk/government/publications/ministerial-gifts-hospitality-travel-and-external-meetings-2014</a></p><p> </p><p>The latest publications up to September 2015 are available at:</p><p> </p><p><a href="https://www.gov.uk/government/publications/ministerial-gifts-hospitality-travel-and-external-meetings-2015" target="_blank">https://www.gov.uk/government/publications/ministerial-gifts-hospitality-travel-and-external-meetings-2015</a></p><p> </p><p>Information for October to December 2015 will be published at the end of March.</p><p> </p><p>Departmental officials have ongoing discussions with representatives from companies producing food and drink. Discussions have included actions and commitments being made by industry to improve the nation’s diet, successes achieved and challenges to make further substantial progress.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 04/02/2016 16:48:25 answering member 3918 label Biography information for Jane Ellison
tabling member	1506 label Biography information for Andrew Gwynne

449399

registered interest
date	01/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prostate Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the potential cost to the NHS of introducing a national prostate cancer screening programme.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	25062
answer	answer is ministerial correction date of answer 04/02/2016 answer text <p>The UK National Screening Committee (UK NSC) recently examined and consulted upon the international peer reviewed evidence regarding prostate cancer screening. The UK NSC recommended against a systematic population screening programme for prostate cancer. This is because the prostate-specific antigen (PSA) is not an accurate enough test for prostate cancer. Additionally, the UK NSC identified that there is still an incomplete understanding of which prostate cancers are aggressive and require treatment and which are safe to actively monitor. There is a significant amount of research activity underway, but currently the evidence suggests that a systematic screening programme would do more harm than good.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 25059 25076 question first answered 04/02/2016 16:47:00 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

449404

registered interest
date	01/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Breast Cancer: Clinical Reference Groups
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions the Breast Cancer Clinical Reference Group has had with organisations in the devolved administrations on the sharing of best practice.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	25065
answer	answer is ministerial correction date of answer 04/02/2016 answer text <p>The Breast Cancer Clinical Reference Group (CRG) was recently set up, by the NHS England National Clinical Director for Cancer, to provide whole pathway consensus clinical advice to commissioners in England. Although the CRG has no formal remit to liaise with the devolved administrations, we recognise the benefit of sharing best practice throughout the United Kingdom and the important role this has in improving services.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 04/02/2016 16:49:33 answering member 3918 label Biography information for Jane Ellison
tabling member	1409 label Biography information for Mr Gregory Campbell

449405

registered interest
date	01/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prostate Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of (a) how many cases of prostate cancer could be identified earlier by a national prostate cancer screening programme and (b) what effect such a programme would have on survival rates.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	25059
answer	answer is ministerial correction date of answer 04/02/2016 answer text <p>The UK National Screening Committee (UK NSC) recently examined and consulted upon the international peer reviewed evidence regarding prostate cancer screening. The UK NSC recommended against a systematic population screening programme for prostate cancer. This is because the prostate-specific antigen (PSA) is not an accurate enough test for prostate cancer. Additionally, the UK NSC identified that there is still an incomplete understanding of which prostate cancers are aggressive and require treatment and which are safe to actively monitor. There is a significant amount of research activity underway, but currently the evidence suggests that a systematic screening programme would do more harm than good.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 25062 25076 question first answered 04/02/2016 16:47:00 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

449407

registered interest
date	01/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prostate Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps the Government is taking to (a) raise awareness and (b) prevent the prevalence of prostate cancer.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	25060
answer	answer is ministerial correction date of answer 04/02/2016 answer text <p>Public Health England (PHE) ran a local pilot campaign from 20 October to 16 November 2014, specifically targeting prostate cancer within Black African-Caribbean men, because of their significantly increased risk of developing prostate cancer. The campaign was delivered in partnership with Prostate Cancer UK and was designed to support their awareness raising activity.</p><p> </p><p>The campaign ran in six London boroughs – Hackney, Haringey, Newham, Southwark, Lambeth and Lewisham – and was delivered mainly through face to face activity, supported by posters in key outdoor locations and in salons and a programme of targeted public relations.</p><p> </p><p>The campaign was delivered in partnership with Prostate Cancer UK and was designed to support their awareness raising activity.</p><p> </p><p>PHE will shortly be re-running the national campaign on “Blood in Pee”. Although primarily aimed at bladder and kidney cancer, blood in the urine can also be a sign of prostate cancer.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 04/02/2016 16:44:49 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

449415

registered interest
date	01/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prostate Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what plans the Government has to introduce a prostate cancer screening programme.
tabling member constituency	West Lancashire
tabling member printed	Rosie Cooper
uin	25076
answer	answer is ministerial correction date of answer 04/02/2016 answer text <p>The UK National Screening Committee (UK NSC) recently examined and consulted upon the international peer reviewed evidence regarding prostate cancer screening. The UK NSC recommended against a systematic population screening programme for prostate cancer. This is because the prostate-specific antigen (PSA) is not an accurate enough test for prostate cancer. Additionally, the UK NSC identified that there is still an incomplete understanding of which prostate cancers are aggressive and require treatment and which are safe to actively monitor. There is a significant amount of research activity underway, but currently the evidence suggests that a systematic screening programme would do more harm than good.</p> answering member constituency Battersea answering member printed Jane Ellison grouped question UIN 25059 25062 question first answered 04/02/2016 16:47:00 answering member 3918 label Biography information for Jane Ellison
tabling member	1538 label Biography information for Rosie Cooper

449428

registered interest
date	01/02/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Electronic Cigarettes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, which vaping or e-cigarette products the NHS can prescribe to help smokers quit; and what the process was for selecting those products.
tabling member constituency	Bishop Auckland
tabling member printed	Helen Goodman
uin	25230
answer	answer is ministerial correction date of answer 04/02/2016 answer text <p>Only e-cigarettes that have been granted a marketing authorisation by the Medicines and Healthcare products Regulatory Agency (MHRA) can be prescribed by the National Health Service.</p><p> </p><p>By law, before a medicine can be placed on the market, it must be given a marketing authorisation (product licence) by a medicines regulator. The United Kingdom regulator is the MHRA. A specially trained panel of medicines assessors reviews all the available evidence arising out of the pre-clinical research and clinical trials. Manufacturers may also be asked to supply additional information. The MHRA also inspects the factory where the medicine is to be made, to make sure that supplies will be of a uniformly and consistently high standard.</p><p><strong> </strong></p><p>To date one e-cigarette, e-Voke (10and 15mg electronic inhalers) has been granted a marketing authorisation by the MHRA. It is, however, not yet commercially available on the UK market to prescribe.</p><p> </p><p>It is a commercial decision whether to apply to a medicines regulator for a marketing authorisation.</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 04/02/2016 16:39:42 answering member 3918 label Biography information for Jane Ellison
tabling member	1484 label Biography information for Helen Goodman